Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 Mar;7(3):322–327. doi: 10.1128/aac.7.3.322

Potentiation of the Toxicity of Mithramycin by Bacterial Lipopolysaccharide

S G Bradley 1, A C Adams 1, M C Smith 1
PMCID: PMC429133  PMID: 124549

Abstract

The lethality for BALB/c mice of 1,3-bis(2-chloroethyl)-1-nitrosourea, cytosine arabinoside, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, hydroxyurea, mithramycin, a polymyxin-like antibiotic (SQ 21,286), polyadenylic polyuridylic acid, procarbazine, 5-[3,3-bis(2-chloroethyl)-1-triazeno]-imidazole-4-carboxamide (TIC-mustard) or uracil arabinoside administered in combination with Escherichia coli lipopolysaccharide (LPS) was measured. Simultaneously administered mithramycin and LPS or TIC-mustard administered 24 h after LPS synergistically killed mice. Concanavalin A potentiated the lethality of TIC-mustard but not of eight other drugs tested. Pretreatment of mice with LPS or lipid A complexed to concanavalin A rendered mice resistant to the lethal action of LPS alone or combinations of LPS and mithramycin. Mithramycin-treated mice were killed by minute amounts of LPS. Mice sensitized to LPS by mithramycin were used to detect endotoxic activity in biological materials, such as commercially available enzymes, and in a complex of lipid A with concanavalin A.

Full text

PDF
322

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bates H. M., Margolin S. Endotoxin-induced inhibition of renal function in the mouse. Proc Soc Exp Biol Med. 1968 Nov;129(2):642–646. doi: 10.3181/00379727-129-33387. [DOI] [PubMed] [Google Scholar]
  2. Dowling J. N., Feldman H. A. Quantitative biological assay of bacterial endotoxins. Proc Soc Exp Biol Med. 1970 Jul;134(3):861–864. doi: 10.3181/00379727-134-34899. [DOI] [PubMed] [Google Scholar]
  3. Eaves A. C., Bruce W. R. Endotoxin-induced sensitivity of hematopoietic stem cells to chemotherapeutic agents. Ser Haematol. 1972;5(2):64–72. [PubMed] [Google Scholar]
  4. Galanos C., Lüderitz O., Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem. 1969 Jun;9(2):245–249. doi: 10.1111/j.1432-1033.1969.tb00601.x. [DOI] [PubMed] [Google Scholar]
  5. Galanos C., Rietschel E. T., Lüderitz O., Westphal O., Kim Y. B., Watson D. W. Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem. 1972 Dec 4;31(2):230–233. doi: 10.1111/j.1432-1033.1972.tb02524.x. [DOI] [PubMed] [Google Scholar]
  6. Klastersky J., Daneau D., Verhest A. Causes of death in patients with cancer. Eur J Cancer. 1972 Apr;8(2):149–154. doi: 10.1016/0014-2964(72)90036-9. [DOI] [PubMed] [Google Scholar]
  7. Marecki N. M., Bradley S. G. Enhanced toxicity for mice of combinations of bacterial endotoxin with antitumor drugs. Antimicrob Agents Chemother. 1973 May;3(5):599–606. doi: 10.1128/aac.3.5.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Meyers E., Pansy F. E., Basch H. I., McRipley R. J., Slusarchyk D. S., Graham S. F., Trejo W. H. EM49, a new peptide antibiotic. 3. biological characterization in vitro and in vivo. J Antibiot (Tokyo) 1973 Aug;26(8):457–462. doi: 10.7164/antibiotics.26.457. [DOI] [PubMed] [Google Scholar]
  9. Peavy D. L., Shands J. W., Jr, Adler W. H., Smith R. T. Mitogenicity of bacterial endotoxins: characterization of the mitogenic principle. J Immunol. 1973 Aug;111(2):352–357. [PubMed] [Google Scholar]
  10. Pieroni R. E., Broderick E. J., Bundeally A., Levine L. A simple method for the quantitation of submicrogram amounts of bacterial endotoxin. Proc Soc Exp Biol Med. 1970 Mar;133(3):790–794. doi: 10.3181/00379727-133-34565. [DOI] [PubMed] [Google Scholar]
  11. Rose W. C., Bradley S. G., Lee I. P. Potentiation of the toxicity of several antitumor agents by Salmonella typhosa endotoxin. Toxicol Appl Pharmacol. 1972 Sep;23(1):102–111. doi: 10.1016/0041-008x(72)90209-8. [DOI] [PubMed] [Google Scholar]
  12. Rose W. C. Interaction of bacterial toxins in the toxicity of chemotherapeutic agents. CRC Crit Rev Toxicol. 1973 Sep;2(2):159–209. doi: 10.3109/10408447309025702. [DOI] [PubMed] [Google Scholar]
  13. Rosenstreich D. L., Asselineau J., Mergenhagen S. E., Nowotny A. A synthetic glycolipid with B-cell mitogenic activity. J Exp Med. 1974 Nov 1;140(5):1404–1409. doi: 10.1084/jem.140.5.1404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Seyberth H. W., Schmidt-Gayk H., Hackenthal E. Toxicity, clearance and distribution of endotoxin in mice as influenced by actinomycin D, cycloheximide, -amanitin and lead acetate. Toxicon. 1972 Aug;10(5):491–500. doi: 10.1016/0041-0101(72)90175-4. [DOI] [PubMed] [Google Scholar]
  15. WARAVDEKAR V. S., SASLAW L. D. A sensitive colorimetric method for the estimation of 2-deoxy sugars with the use of the malonaldehyde-thiobarbituric acid reaction. J Biol Chem. 1959 Aug;234(8):1945–1950. [PubMed] [Google Scholar]
  16. Yarbro J. W., Kennedy B. J., Barnum C. P. Hydroxyurea inhibition of DNA synthesis in ascites tumor. Proc Natl Acad Sci U S A. 1965 May;53(5):1033–1035. doi: 10.1073/pnas.53.5.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yarbro J. W., Kennedy B. J., Barnum C. P. Mithramycin inhibition of ribonucleic acid synthesis. Cancer Res. 1966 Jan;26(1):36–39. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES